These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24111526)

  • 1. Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents.
    Wermuth PJ; Jimenez SA
    Clin Exp Immunol; 2014 Jan; 175(1):113-25. PubMed ID: 24111526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis.
    Piera-Velazquez S; Louneva N; Fertala J; Wermuth PJ; Del Galdo F; Jimenez SA
    Ann Rheum Dis; 2010 Nov; 69(11):2017-23. PubMed ID: 20570839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.
    Wermuth PJ; Jimenez SA
    J Immunol; 2012 Jul; 189(1):318-27. PubMed ID: 22649203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents.
    Wermuth PJ; Del Galdo F; Jiménez SA
    Arthritis Rheum; 2009 May; 60(5):1508-18. PubMed ID: 19404939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis.
    Del Galdo F; Wermuth PJ; Addya S; Fortina P; Jimenez SA
    Ann Rheum Dis; 2010 Nov; 69(11):2024-33. PubMed ID: 20959327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic systemic fibrosis.
    Bardin T; Richette P
    Curr Opin Rheumatol; 2010 Jan; 22(1):54-8. PubMed ID: 19881349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.
    Swaminathan S; Bose C; Shah SV; Hall KA; Hiatt KM
    Am J Pathol; 2013 Sep; 183(3):796-807. PubMed ID: 23867799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type of MRI contrast, tissue gadolinium, and fibrosis.
    Do C; Barnes JL; Tan C; Wagner B
    Am J Physiol Renal Physiol; 2014 Oct; 307(7):F844-55. PubMed ID: 25100280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
    Bose C; Megyesi JK; Shah SV; Hiatt KM; Hall KA; Karaduta O; Swaminathan S
    PLoS One; 2015; 10(8):e0136563. PubMed ID: 26305890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of NSF: New evidence challenging the prevailing theory.
    Newton BB; Jimenez SA
    J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
    Nazarian RM; Mandal RV; Kagan A; Kay J; Duncan LM
    J Am Acad Dermatol; 2011 Apr; 64(4):741-7. PubMed ID: 21414498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents.
    Hoppe H; Spagnuolo S; Froehlich JM; Nievergelt H; Dinkel HP; Gretener S; Thoeny HC
    Eur Radiol; 2010 Mar; 20(3):595-603. PubMed ID: 19760239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model.
    Wagner B; Tan C; Barnes JL; Ahuja S; Davis TL; Gorin Y; Jimenez F
    Am J Pathol; 2012 Dec; 181(6):1941-52. PubMed ID: 23041060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts.
    Ozawa Y; Hayashi S; Hamasaki Y; Hatamochi A
    Arch Dermatol Res; 2016 Dec; 308(10):695-701. PubMed ID: 27683230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
    Gupta A; Shamseddin MK; Khaira A
    Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2.
    Do C; Drel V; Tan C; Lee D; Wagner B
    J Invest Dermatol; 2019 Oct; 139(10):2134-2143.e2. PubMed ID: 30978353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelin-1/endothelin receptor signaling in fibrosis and calcification in nephrogenic systemic fibrosis.
    Motegi S; Okada E; Uchiyama A; Yamada K; Ogino S; Yokoyama Y; Takeuchi Y; Monma F; Suzuki T; Ishikawa O
    Exp Dermatol; 2014 Sep; 23(9):664-9. PubMed ID: 25048859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of magnetic resonance imaging contrast agents on human umbilical vein endothelial cells and evaluation of magnetic resonance imaging contrast media-triggered transforming growth factor-beta induction in dermal fibroblasts (HSF) as a model for nephrogenic systemic fibrosis.
    Wiesinger B; Kehlbach R; Hemsen J; Bebin J; Bantleon R; Schwenzer N; Spira D; Claussen CD; Wiskirchen J
    Invest Radiol; 2011 Jan; 46(1):71-6. PubMed ID: 21139503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.
    Sieber MA; Lengsfeld P; Frenzel T; Golfier S; Schmitt-Willich H; Siegmund F; Walter J; Weinmann HJ; Pietsch H
    Eur Radiol; 2008 Oct; 18(10):2164-73. PubMed ID: 18545998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
    Edward M; Quinn JA; Burden AD; Newton BB; Jardine AG
    Radiology; 2010 Sep; 256(3):735-43. PubMed ID: 20663970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.